TY  - JOUR

T1  - The impact of tralokinumab on quality of life and school in patients aged 12–17 with atopic dermatitis: results from the phase 3 ECZTRA 6 trial

JO  - SKIN The Journal of Cutaneous Medicine

UR  - http://dx.doi.org/10.25251/skin.6.supp.77

PY  - 2022/11/16

AU  - Paller AS

AU  - Silverberg JI

AU  - Hong C-H

AU  - Cork M

AU  - Puig L

AU  - Arlert P

AU  - Kurbasic A

AU  - Soldbro L

AU  - Simpson EL

ED  - 

DO  - DOI: 10.25251/skin.6.supp.77

PB  - National Society for Cutaneous Medicine

VL  - 6

IS  - 6

SP  - s77

EP  - s77

Y2  - 2024/12/22

ER  -